Literature DB >> 22972234

Host-cell factors involved in papillomavirus entry.

Luise Florin1, Martin Sapp, Gilles A Spoden.   

Abstract

Papillomaviruses infect skin and mucosa where they induce warts and cancers. For entry to occur, they sequentially engage numerous host proteins, allowing them to deliver their genetic information into target cells. This multistep process starts with initial binding via its L1 major capsid protein, followed by structural changes of the capsid on the cell surface, engagement of different receptors, and endocytosis. The post-entry phase includes capsid disassembly, endosomal escape of a complex of the minor capsid protein L2 and the viral genome, its transport into the nucleus, and accumulation at nuclear substructures. This review summarizes the current knowledge of the papillomavirus entry pathway and the role of cellular proteins involved in this course of events.

Entities:  

Mesh:

Year:  2012        PMID: 22972234     DOI: 10.1007/s00430-012-0270-1

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   4.148


  118 in total

1.  Human alpha-defensins block papillomavirus infection.

Authors:  Christopher B Buck; Patricia M Day; Cynthia D Thompson; Jacek Lubkowski; Wuyuan Lu; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 2.  Pathways of clathrin-independent endocytosis.

Authors:  Satyajit Mayor; Richard E Pagano
Journal:  Nat Rev Mol Cell Biol       Date:  2007-08       Impact factor: 94.444

Review 3.  Structure, attachment and entry of polyoma- and papillomaviruses.

Authors:  Martin Sapp; Patricia M Day
Journal:  Virology       Date:  2009-01-21       Impact factor: 3.616

4.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.

Authors:  Hans-Ulrich Bernard; Robert D Burk; Zigui Chen; Koenraad van Doorslaer; Harald zur Hausen; Ethel-Michele de Villiers
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

5.  Human papillomavirus infection requires cell surface heparan sulfate.

Authors:  T Giroglou; L Florin; F Schäfer; R E Streeck; M Sapp
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 6.  The emerging role of tetraspanin microdomains on endothelial cells.

Authors:  Rebecca L Bailey; John M Herbert; Kabir Khan; Victoria L Heath; Roy Bicknell; Michael G Tomlinson
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

7.  alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP.

Authors:  C S Yoon; K D Kim; S N Park; S W Cheong
Journal:  Biochem Biophys Res Commun       Date:  2001-05-11       Impact factor: 3.575

8.  Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization.

Authors:  Katrin A Becker; Luise Florin; Cornelia Sapp; Martin Sapp
Journal:  Virology       Date:  2003-09-15       Impact factor: 3.616

9.  Interaction of papillomaviruses with the cell surface.

Authors:  R B Roden; R Kirnbauer; A B Jenson; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

10.  Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs).

Authors:  Gilles Spoden; Kirsten Freitag; Matthias Husmann; Klaus Boller; Martin Sapp; Carsten Lambert; Luise Florin
Journal:  PLoS One       Date:  2008-10-02       Impact factor: 3.240

View more
  23 in total

Review 1.  Principles of polyoma- and papillomavirus uncoating.

Authors:  Carla Cerqueira; Mario Schelhaas
Journal:  Med Microbiol Immunol       Date:  2012-09-23       Impact factor: 3.402

Review 2.  The papillomavirus major capsid protein L1.

Authors:  Christopher B Buck; Patricia M Day; Benes L Trus
Journal:  Virology       Date:  2013-06-22       Impact factor: 3.616

3.  Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.

Authors:  Mayim E Wiens; Jason G Smith
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

4.  The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.

Authors:  Marc A Schneider; Konstanze D Scheffer; Timo Bund; Fatima Boukhallouk; Carsten Lambert; Cristina Cotarelo; Gert O Pflugfelder; Luise Florin; Gilles A Spoden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 5.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

6.  Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry.

Authors:  Gilles Spoden; Lena Kühling; Nicole Cordes; Bettina Frenzel; Martin Sapp; Klaus Boller; Luise Florin; Mario Schelhaas
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

7.  The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.

Authors:  Elena Wüstenhagen; Laura Hampe; Fatima Boukhallouk; Marc A Schneider; Gilles A Spoden; Inka Negwer; Kaloian Koynov; W Martin Kast; Luise Florin
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

8.  Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure.

Authors:  Carla Cerqueira; Yan Liu; Lena Kühling; Wengang Chai; Wali Hafezi; Toin H van Kuppevelt; Joachim E Kühn; Ten Feizi; Mario Schelhaas
Journal:  Cell Microbiol       Date:  2013-05-06       Impact factor: 3.715

9.  Tetraspanin CD151 mediates papillomavirus type 16 endocytosis.

Authors:  Konstanze D Scheffer; Alexander Gawlitza; Gilles A Spoden; Xin A Zhang; Carsten Lambert; Fedor Berditchevski; Luise Florin
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

Review 10.  The tetraspanin CD151 in papillomavirus infection.

Authors:  Konstanze D Scheffer; Fedor Berditchevski; Luise Florin
Journal:  Viruses       Date:  2014-02-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.